Two major leaps in AI-powered drug discovery
AI + Medicine Newsletter 2024–03–12
2 min readMar 14, 2024
1. From AI to Clinical Trials: Fast-tracking Anti-fibrotic Drug Development
The AI-predicted TNIK inhibitor, INS018_055, showcases a rapid transition from AI-based target discovery to clinical validation, offering a new treatment avenue for fibrosis. This study from Insilico Medicine, one of the pioneers in AI for drug discovery, highlights the efficiency of AI in drug discovery, evidenced by the swift 18-month…
